These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 21128858)
1. Bcl-X(L) is the primary mediator of p21 protection against hyperoxia-induced cell death. Wu YC; O'Reilly MA Exp Lung Res; 2011 Mar; 37(2):82-91. PubMed ID: 21128858 [TBL] [Abstract][Full Text] [Related]
2. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner. Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306 [TBL] [Abstract][Full Text] [Related]
3. Vesicular stomatitis virus induces apoptosis primarily through Bak rather than Bax by inactivating Mcl-1 and Bcl-XL. Pearce AF; Lyles DS J Virol; 2009 Sep; 83(18):9102-12. PubMed ID: 19587033 [TBL] [Abstract][Full Text] [Related]
4. p21(Cip1/Waf1/Sdi1) protects against hyperoxia by maintaining expression of Bcl-X(L). Staversky RJ; Vitiello PF; Gehen SC; Helt CE; Rahman A; Keng PC; O'Reilly MA Free Radic Biol Med; 2006 Aug; 41(4):601-9. PubMed ID: 16863993 [TBL] [Abstract][Full Text] [Related]
5. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells. Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214 [TBL] [Abstract][Full Text] [Related]
6. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Chen S; Dai Y; Harada H; Dent P; Grant S Cancer Res; 2007 Jan; 67(2):782-91. PubMed ID: 17234790 [TBL] [Abstract][Full Text] [Related]
7. Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma. Gillissen B; Wendt J; Richter A; Richter A; Müer A; Overkamp T; Gebhardt N; Preissner R; Belka C; Dörken B; Daniel PT J Cell Biol; 2010 Mar; 188(6):851-62. PubMed ID: 20308427 [TBL] [Abstract][Full Text] [Related]
8. Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1. Du X; Youle RJ; FitzGerald DJ; Pastan I Mol Cell Biol; 2010 Jul; 30(14):3444-52. PubMed ID: 20457813 [TBL] [Abstract][Full Text] [Related]
9. p21Cip1 protection against hyperoxia requires Bcl-XL and is uncoupled from its ability to suppress growth. Vitiello PF; Staversky RJ; Gehen SC; Johnston CJ; Finkelstein JN; Wright TW; O'Reilly MA Am J Pathol; 2006 Jun; 168(6):1838-47. PubMed ID: 16723699 [TBL] [Abstract][Full Text] [Related]
10. Differential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1. Zhai D; Jin C; Huang Z; Satterthwait AC; Reed JC J Biol Chem; 2008 Apr; 283(15):9580-6. PubMed ID: 18178565 [TBL] [Abstract][Full Text] [Related]
11. PUMA inactivation protects against oxidative stress through p21/Bcl-XL inhibition of bax death. Vitiello PF; Staversky RJ; Keng PC; O'Reilly MA Free Radic Biol Med; 2008 Feb; 44(3):367-74. PubMed ID: 18215742 [TBL] [Abstract][Full Text] [Related]
12. In non-transformed cells Bak activates upon loss of anti-apoptotic Bcl-XL and Mcl-1 but in the absence of active BH3-only proteins. Senft D; Weber A; Saathoff F; Berking C; Heppt MV; Kammerbauer C; Rothenfusser S; Kellner S; Kurgyis Z; Besch R; Häcker G Cell Death Dis; 2015 Nov; 6(11):e1996. PubMed ID: 26610208 [TBL] [Abstract][Full Text] [Related]
14. p21(Cip1) protects against oxidative stress by suppressing ER-dependent activation of mitochondrial death pathways. Vitiello PF; Wu YC; Staversky RJ; O'Reilly MA Free Radic Biol Med; 2009 Jan; 46(1):33-41. PubMed ID: 18948188 [TBL] [Abstract][Full Text] [Related]
15. MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor. Xiao Y; Nimmer P; Sheppard GS; Bruncko M; Hessler P; Lu X; Roberts-Rapp L; Pappano WN; Elmore SW; Souers AJ; Leverson JD; Phillips DC Mol Cancer Ther; 2015 Aug; 14(8):1837-47. PubMed ID: 26013319 [TBL] [Abstract][Full Text] [Related]
16. IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins. Waxman AB; Kolliputi N Am J Respir Cell Mol Biol; 2009 Oct; 41(4):385-96. PubMed ID: 19168699 [TBL] [Abstract][Full Text] [Related]
18. MCL-1 inhibits BAX in the absence of MCL-1/BAX Interaction. Germain M; Milburn J; Duronio V J Biol Chem; 2008 Mar; 283(10):6384-92. PubMed ID: 18089567 [TBL] [Abstract][Full Text] [Related]
19. Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization. Meng XW; Lee SH; Dai H; Loegering D; Yu C; Flatten K; Schneider P; Dai NT; Kumar SK; Smith BD; Karp JE; Adjei AA; Kaufmann SH J Biol Chem; 2007 Oct; 282(41):29831-46. PubMed ID: 17698840 [TBL] [Abstract][Full Text] [Related]
20. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Kim H; Rafiuddin-Shah M; Tu HC; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH Nat Cell Biol; 2006 Dec; 8(12):1348-58. PubMed ID: 17115033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]